PHARMANIAGA Berhad’s work to develop local capability for the PCV13 pneumococcal vaccine, through technology transfer and collaboration with its partners, is one example of how it hopes to bring innovation closer to home while gradually building the knowledge and capabilities that can contribute to Malaysia’s medicine security.